Shock wave lithotripsy in patients requiring anticoagulation or antiplatelet agents

Authors

  • Bader Alsaikhan Department of Urology, McGill University Health Centre, Montreal, QC
  • Sero Andonian Department of Urology, McGill University Health Centre, Montreal, QC

DOI:

https://doi.org/10.5489/cuaj.566

Abstract

Extracorporeal shockwave lithotripsy (SWL) remains the only truly
minimally invasive procedure for the treatment of upper tract nephrolithiasis.
Recently, there has been a recent rise in the patients
on antiplatelet agents. Therefore, the aim of the present study is
to review the literature available regarding SWL in these high-risk
patients requiring anti-coagulation therapy. Alternative therapies
to SWL are also presented.

Downloads

Download data is not yet available.

Author Biographies

Bader Alsaikhan, Department of Urology, McGill University Health Centre, Montreal, QC

Sero Andonian, Department of Urology, McGill University Health Centre, Montreal, QC

Downloads

How to Cite

Alsaikhan, B., & Andonian, S. (2013). Shock wave lithotripsy in patients requiring anticoagulation or antiplatelet agents. Canadian Urological Association Journal, 5(1), 53–7. https://doi.org/10.5489/cuaj.566

Issue

Section

Review